Over 20 years ago, scientists envisioned producing medicines from genetically modified crops, but producing edible vaccines from food crops proved more difficult than expected. Currently, only 11 plant species are approved for growing pharmaceuticals through clinical trials. Scientists are working to increase protein production in plants and maintain consistent dosing. Advocates believe pharmaceutical crops could lower medicine costs and improve access, but challenges remain regarding safety, contamination, and environmental impacts.